Paul Sauer - 23 May 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
Paul Sauer, by /s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
23 May 2022
Net transactions value
-$78,670
Form type
4
Filing time
25 May 2022, 16:24:56 UTC
Previous filing
26 Apr 2022
Next filing
22 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $78,670 -3,000 -11% $26.22 23,687 23 May 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.72 to $26.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 1,562 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.